Effects of sevoflurane on postoperative liver functions in morbidly obese as compared to the non-obese patients

Middle East Journal of Anesthesiology

Volumn 20, Issue 2, 2009, Pages 207-212

  Al Ghanem, Subhi M ^a   Massad, Islam M ^a   Al Barazangi, Bassam ^a   Al Mustafa, Mahmoud ^a   Daoud, Fayez S ^a   Abu Ali, Hamdi ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Liver enzymes; Morbid obesity; Sevoflurane

Indexed keywords

ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; SEVOFLURANE;

ABDOMEN; ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LIVER; LIVER FUNCTION TEST; MALE; METABOLISM; MIDDLE AGED; MORBID OBESITY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; TIME; UNIVERSITY HOSPITAL;

ABDOMEN; ADOLESCENT; ADULT; AGED; ANESTHETICS, INHALATION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; METHYL ETHERS; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 67650433552     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Brown BR Jr, Gandolfi AJ: Adverse effects of volatile anesthetics. Br J Anaesth; 1987, 59:14.
2. Stock JGL, Strunin L: Unexplained hepatitis following halothane. Anesthesiology; 1985, 63:424.
3. Bottinger LE, Dalen E, Hallen B: Halothane-induced liver damage: An analysis of the material reported to the Swedish Adverse Drug Reaction Committee 1966-1973. Acta Anaesthesiol Scand; 1976, 20:40.
4. Farrell G, Prendergast D, Murray M: Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med; 1985, 313:1310.
5. Otsuka S, Yamamoto M, Kasuya S, et al: HLA antigens in patients with unexplained hepatitis following halothane anesthesia. Acta Anesthesiol Scand; 1985, 29:497.
6. Brunt EM, White H, Marsh JW, Holtmann B, Peters MG: Fluminant hepatic failure after repeate exposure to isoflurane anesthesia: a case report. Hepatology; 1991, 13:1017-21.
7. Weitz J, Kienle P, B'hrer H, Hofmann W, Theilmann L, Otto G: Fatal Hepatic necrosis after isoflurane anesthesia. Anesthesia; 1997, 52:892-5.
8. Cousins MJ, Plummer JL, Hall PD: Risk factor for halothane hepatitis. Aust N Z Surg; 1989, 59:5-14.
9. Jackie L, Martin MD: Volatile anesthetics and liver injury: a clinical update or what every anesthesiologist should know: Can J Anesth; 2005, 52: 2, pp.125-129.
10. Behne M, Wilke HJ, Harder S: Clinical Pharmacokinetics of sevoflurane. Clin Pharmacokinet; 1999 Jan, 36(1):13-26.
11. Ogawa M, Doi K, Mitsufuji T, et al: Drug induced hepatitis following sevoflurane anesthesia in a child. Masui; 1991, 40:1542-1545.
12. Shichinohe Y, Masuda Y, Takahashi H, et al: A case of postoperative hepatic injury after sevoflurane anesthesia. Masui; 1992, 41:1802-1805.
13. Watanabe K, Hatakenaka S, Ikemune K, et al: A case of suspected liver dysfunction induced by sevoflurane anesthesia. Masui; 1993, 42:902-905.
14. Kayashima K, Matsumoto T, Sata T, et al: A case of severe liver dysfunction after sevoflurane anesthesia. Rinsho Masui; 1995, 19:53-55.
15. Tsujimoto S, Kato H, Minamoto Y, Miki H, Kitamura R: Comparison of postoperative liver dysfunction following halothane and sevoflurane anesthesia in women undergoing mastectomy for cancer. J Anesth; 1995, 9:129-134.
16. Nishiyama T, Watanabe S, Kobayashi Y, Nagase M: Liver and renal functions after sevoflurane anesthesia-in comparison with enflurane anesthesia. Anesth Resus; 1995, 31:145-148.
17. Nishiyama T, Yokoyama T, Hanaoka K: Effect of sevoflurane and isoflurane anesthesia on arterial ketone body ratio and liver funtion. Acta Anaesthesiol Scand; 1999, 43:347-351.
18. Yasuyuki Iwanaga, Hisao Komatsu, Satoshi Yokono, Kenji Ogil: Serum glutathione S-transferase alpha as a measure of hepatocellular function following prolonged anaesthesia with sevoflurane and halothane in paediatric patients. Pediatric Anesthesia; July 2000, volume 10, Issue 4, p. 395.
19. Tomoki Nishiyama MD PhD, Takeshi Yokoyama DDS PhD, Kazuo Hanoks MD PhD: Liver function after sevoflurane or isoflurane anaesthesia in neurosurgical patients. Can J Anaesth; 1998, 45:8, pp. 753-756.
20. Gelman S, Fowler KC, Smith LR: Liver Circulation and function during isoflurane and halothane anesthesia. Anesthesiology; 1984,61:726-730.
21. Goldfarb G, Debaene B, Ang ET, Roult D, Jolies P, Lebrec D: Hepatic blood flow in humans during isoflurane - N2O and Halothane - N2O anaesthesia. Anesth Analg; 1990, 71:349-353.
22. Lined RC, Gandolfi AJ, Hall PM: Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pigs. Anesthesiology; 1990, 73:1208-13.
23. Iaizzo PA, Seewald MJ, Powis G, Phil D, Van Dyke RA: The effect of volatile anesthetics on Ca++mobilization in rat hepatocytes. Anesthesiology; 1990, 72:504-9.
24. Njoku D, Laster MJ, Gong DH, et al: Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacertylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg; 1997, 84:173-8.
25. Hongo T: Sevoflurane reduced but isoflurane maintained hepatic blood flow during anesthesia in man. Masui; 1994, 8:55-59.
26. Sugai M: Comparison of the effect of isoflurane and that of Sevoflurane on hepatic circulation and oxygen metabolism during acute hypoxia in dogs. Masui; 1996, 45:608-16.
27. Kobayashi M: The effect of Sevoflurane and isoflurane on hepatic blood flow in man. Masui; 1996, 45:281-6.
28. Miyoshi S: Hepatic effects of sevoflurane - the changes of drug metabolizing enzyme and morphologic features. Masui; 1988,37:414-419.
29. Holaday DA, Smith FR: Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology; 1981,54:100-6.
30. Ryoji Obata MD, Hiromichi Bito MD, Morihiro Ohmura, Goroku Moriwaki MD, Yukako Ikeuchi MD, Takasumi Katoh MD, Shigehito Sato MD: The Effect of Prolonged Low-Flow Sevoflurane Anesthesia on Renal and Hepatic Function. Anesth Analg; 2000,91:1262-1268.
31. Sear JW: Toxicity of IV anesthetics. Br Anaesth; 1987, 59:24-45.